Do you have to stay on weight loss injections forever?

What the trial data tell us about stopping

The question our prescribers hear most weeks isn't whether these medicines work, it's what happens when people come off them. The answer, from published evidence, is sobering but important to understand. In the STEP 1 extension study, participants who stopped semaglutide 2.4mg after 68 weeks regained roughly two thirds of the weight they had lost within 12 months of discontinuation. Body-weight, blood pressure and metabolic markers largely returned toward their pre-treatment levels too. A comparable pattern was observed in follow-up data from the tirzepatide SURMOUNT programme. The STEP 1 trial, published in the New England Journal of Medicine, was among the first to document this rebound clearly, and it changed how clinicians frame duration conversations.

What this means in practice: these medicines work by continuing to signal satiety hormones. Once stopped, those signals fade and appetite returns to its previous baseline for most people. That is biology, not a failure of willpower. Weight is regulated by complex hormonal systems, and for many people these medicines effectively correct a signal that was underperforming. If you are wondering whether you have to be on weight loss injections forever, the honest answer is that stopping removes that hormonal correction, which is why duration decisions deserve careful thought. Understanding this upfront helps you and your prescriber plan treatment around your actual health goals, rather than treating it as a short course.

What the rules say, and where NHS and private differ

Licensing and commissioning guidance adds a layer of nuance. NICE's recommendation for semaglutide (Wegovy) under NHS commissioning (NICE technology appraisal TA875) specifies a maximum of two years of treatment within specialist weight management services. If someone hasn't achieved at least 5% weight loss after six months at the maintenance dose, continuing is not recommended. That two-year boundary is specific to the NHS commissioning pathway for Wegovy; it is not a hard limit in the medicine's licence itself.

Tirzepatide (Mounjaro) carries no equivalent NHS time cap in its current NICE recommendation. NICE's appraisal of tirzepatide (TA1026) focuses on BMI thresholds and comorbidities rather than specifying a maximum duration. NICE does include the same six-month review point: if less than 5% of body weight has been lost by then, the prescriber should reassess whether continuing makes sense.

For people accessing weight loss injections privately, the duration is guided by clinical judgement at each review. At nume, every repeat order is assessed by a GPhC-registered prescriber before being approved, there is no automatic continuation. That ongoing clinical oversight is partly what allows private treatment to remain open-ended where it is medically appropriate, without the commissioning constraints that shape NHS pathways.

Planning around stopping: what a sensible approach looks like

For people who do stop, the evidence points toward keeping the lifestyle changes built during treatment as the main protective factor. Dietary patterns, activity habits and sleep quality all influence how much weight is regained. None of that is easy, and prescribers are realistic about it, no one is told simply to eat less and try harder. The conversation is about which changes have become sustainable and which supports (dietitian, structured programme, GP monitoring) can continue after the injection is stopped.

Some people, particularly those with significant obesity-related health conditions, may continue treatment long-term on clinical grounds. That is a legitimate, medically supervised choice, not dependence. It is also worth knowing that certain other medications, such as those used in hormone treatment, can affect body composition in ways covered in our guide to Prostap injection and weight loss, which is relevant context if you are managing more than one condition alongside your weight. If you are thinking about what using weight loss injections long-term looks like in practice, or wondering how long you'd need to take them to see lasting benefit, those are exactly the conversations that belong in a consultation rather than a search box.

One practical note: when stopping, there's no medical need for a tapering dose schedule for most people (unlike some other medicines), though your prescriber will confirm this for your situation. Any decision to stop should go through your clinical team so your progress can be documented and a plan put in place, abrupt stopping is medically low-risk but leaving without a plan is where the rebound statistics become real.

What this means for choosing treatment in the first place

Framing weight loss injections as a temporary fix misrepresents how they work and sets people up for disappointment. Framing them as a permanent commitment can be equally off-putting. The honest picture sits between those two: they are a clinically supervised tool, used for as long as the benefit outweighs any risks and costs, with regular review points built in. For some people that is 12 months. For others it is several years or more.

If you're weighing up your options (including how treatment fits around other medications, health conditions or plans) a look at the full weight loss treatment options we offer can help you see the range available. Costs vary by medicine and dose; you can find current treatment pricing and eligibility information on our treatment overview page. And if you want to understand the clinical team making these decisions at nume, our lead prescriber's profile is there to read.

These medicines are prescription-only for good reason. The question of how long to stay on them (or whether to start) is one a clinician should help you answer, based on your health, your goals and the latest evidence.